Amy Elazzouzi, Senior Vice President, Finance at Aura Biosciences, Inc. (AURA), sold 8,549 shares at $5.06 ($43K) on 2026-02-17, disclosed to the SEC on 2026-02-17.
Open-market sale of $43k AURA by Senior Vice President, Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AURA | SELL | 2025-08-18 | $103K | — | Filing → |
| AURA | SELL | 2025-04-16 | $5K | — | Filing → |
| AURA | SELL | 2025-02-18 | $11K | — | Filing → |